Jeuveau – The Newest Neurotoxin
Jeuveau is the first product of its kind – an injectable treatment that temporarily improves frown lines.On February 1, 2019 the FDA approved the latest cutting-edge injectable containing Botulinum Toxin A— Jeuveau™ by Evolus.
What Is Jeuveau Injectable?
Jeuveau VS Botox®:
Botox has been in the market since the 90’s, we have been successfully treating patients with Botox for many years. Jeuveau is the first new Botox alternative in a decade. As the fourth neurotoxin to hit the market, Jeuveau is made using a state-of-the-art manufacturing process called Hi-Pure™ technology. Jeuveau is the first product from Evolus, and part of its mission to bring a fresh experience and perspective to the aesthetics industry.
Jeuveau works like other neuromodulator injectables such as Botox, Jeuveau stops muscle movements to erase frown lines and prevent wrinkles. You may notice results within a few days after the procedure, but it can take up to a week to see the full effect. Most patients report that Jeuveau lasts from 4-6 months after treatment. Individual results may vary.
See full prescribing information here: https://info.evolus.com/hubfs/JEUVEAU-CONSUMER-Important-Safety-Information.pdf